MedPath

To study the effect of duralabhadi kashaya ghanvati and levofloxacin in urinary tract infectio

Phase 2
Conditions
Health Condition 1: N390- Urinary tract infection, site notspecified
Registration Number
CTRI/2023/10/058212
Lead Sponsor
Parul Institute of ayurved
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Lakshana of Mutrakrichra which are similar to lower urinary tract infections like Burning (Sadahamutrata), Dysuria (Sarujamutrata), Frequency (Muhur-Muhurmutrata), urgency, strangury and Suprapubic tenderness.

2. Patient suffering from fever.

3. Laboratory investigations showing pus cells in urine more than 5 pus cells/HPF.

4. Subjective parameter score total more than or equal to 6.

Exclusion Criteria

1. Patients not willing for trial.

2. Patients suffering from medical illness like Poly-cystic kidneys, Hydronephrosis, Impaired renal functions, Malignancy of genito- urinary tract, Immuno-compromised patient, Uncontrolled Hypertension, Diabetes.

3. Patients suffering from white discharge per vagina.

4. Pregnant women suffering from UTI.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Beneficial for urinary tract infectionTimepoint: 7 days with 7 days follow up
Secondary Outcome Measures
NameTimeMethod
Also reduce symptoms like burning micturition (sadaha mutrata), frequency (muhur muhur mutrata), dysuria (sarujamutrata), urgency, stranguryTimepoint: Duration of medicine- 7 days <br/ ><br>Assessment will be done on 0,7th & 14th day
© Copyright 2025. All Rights Reserved by MedPath